Blockbuster drugs : the rise and fall of the pharmaceutical industry / / Jie Jack Li |
Autore | Li Jie Jack |
Pubbl/distr/stampa | Oxford ; ; New York : , : Oxford University Press, , [2014] |
Descrizione fisica | 1 online resource (238 p.) |
Disciplina | 338.4/76151 |
Collana | Oxford scholarship online |
Soggetto topico |
Drugs - United States
Pharmaceutical industry - United States - History |
Soggetto genere / forma | Electronic books. |
ISBN |
0-19-756301-5
0-19-991192-4 0-19-990904-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Machine generated contents note: -- Table of Contents Chapter 1 Before the Age of Blockbuster Drugs Chapter 2 The Beginning of an Era - The First Blockbuster Drug Tagamet Chapter 3 More Blockbuster Drugs for Ulcer Chapter 4 Antihistamines as Allergy Medicines Chapter 5 Blood Thinners, From Heparin to Plavix Chapter 6 Conquest of Pain--Analgesics: from Morphine to Lyrica Chapter 7 Lessons Bibliography Appendix Index. |
Record Nr. | UNINA-9910453771703321 |
Li Jie Jack | ||
Oxford ; ; New York : , : Oxford University Press, , [2014] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Blockbuster drugs : the rise and fall of the pharmaceutical industry / / Jie Jack Li |
Autore | Li Jie Jack |
Pubbl/distr/stampa | Oxford ; ; New York : , : Oxford University Press, , [2014] |
Descrizione fisica | 1 online resource (238 p.) |
Disciplina | 338.4/76151 |
Collana | Oxford scholarship online |
Soggetto topico |
Drugs - United States
Pharmaceutical industry - United States - History |
ISBN |
0-19-756301-5
0-19-991192-4 0-19-990904-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Machine generated contents note: -- Table of Contents Chapter 1 Before the Age of Blockbuster Drugs Chapter 2 The Beginning of an Era - The First Blockbuster Drug Tagamet Chapter 3 More Blockbuster Drugs for Ulcer Chapter 4 Antihistamines as Allergy Medicines Chapter 5 Blood Thinners, From Heparin to Plavix Chapter 6 Conquest of Pain--Analgesics: from Morphine to Lyrica Chapter 7 Lessons Bibliography Appendix Index. |
Record Nr. | UNINA-9910790780603321 |
Li Jie Jack | ||
Oxford ; ; New York : , : Oxford University Press, , [2014] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Blockbuster drugs : the rise and fall of the pharmaceutical industry / / Jie Jack Li |
Autore | Li Jie Jack |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Oxford ; ; New York : , : Oxford University Press, , [2014] |
Descrizione fisica | 1 online resource (238 p.) |
Disciplina | 338.4/76151 |
Collana | Oxford scholarship online |
Soggetto topico |
Drugs - United States
Pharmaceutical industry - United States - History |
ISBN |
0-19-756301-5
0-19-991192-4 0-19-990904-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Machine generated contents note: -- Table of Contents Chapter 1 Before the Age of Blockbuster Drugs Chapter 2 The Beginning of an Era - The First Blockbuster Drug Tagamet Chapter 3 More Blockbuster Drugs for Ulcer Chapter 4 Antihistamines as Allergy Medicines Chapter 5 Blood Thinners, From Heparin to Plavix Chapter 6 Conquest of Pain--Analgesics: from Morphine to Lyrica Chapter 7 Lessons Bibliography Appendix Index. |
Record Nr. | UNINA-9910806804503321 |
Li Jie Jack | ||
Oxford ; ; New York : , : Oxford University Press, , [2014] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Cracking the code [[electronic resource] ] : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi |
Autore | Mellon Jim |
Pubbl/distr/stampa | Chichester, West Sussex, U.K., : Wiley, 2012 |
Descrizione fisica | 1 online resource (362 p.) |
Disciplina | 338.4/76151 |
Altri autori (Persone) | ChalabiAl |
Soggetto topico |
Biotechnology industries - Finance
Pharmaceutical industry - Finance Biotechnology industries Pharmaceutical industry Investments |
Soggetto genere / forma | Electronic books. |
ISBN |
1-119-96937-9
1-280-67915-8 9786613656087 1-119-96936-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cracking the Code; Contents; Acknowledgements; Introduction; ChapterOne: Transformational Technologies; Futurists and Scientists Look into the Future; The Convergence of Technology and Biology; ChapterTwo: The Evolution of Medicine and the Emergence of Biopharma; From Atoms to Cells to Living Organisms; The History of the Pharmaceutical Industry; ChapterThree: The Drug Industry - Reinventing the Model; Big Pharma, Biopharma; Drug Patents; The Path to Riches: FDA Approval; In Summary; ChapterFour: Curing Disease - Promising Prospects in the Main Therapeutic Areas
Cancer - Step by Step, Being BeatenInfectious Diseases: New Antibiotics, Hepatitis and HIV Drugs Make for a Fast-growing Sector; Obesity and its Evil Sisters: Type 2 Diabetes and Kidney Disease; The Heart of the Matter - Biggest Killer on the Prowl; Fading into the Night - Neurodegeneration, Rheumatology and Multiple Sclerosis; Respiratory Disease - New Drugs: A Breath of Fresh Air; Rare Diseases and Rare Profits; Drugs for Pain and for the Central Nervous System; The Best of the Rest - Ophthalmology, Dermatology, Gastrointestinal and Bone Disease ChapterFive: Turning Back the Clock - Stem Cells, Genomics, Gene Therapy and RegenerationStem Cells; Gene Therapy and Nano Medicine; Organ Growth in and out of the Body; ChapterSix: Demographic Changes; The Working Age Labour Pool in the World is Shrinking; Can Immigration Solve the Labour Shortage in the Developed World?; The Social Impact of an Ageing Population; The United States is the Best Positioned Developed Country; Support Ratios Have Been Plummeting; China's Grey Future; What Can Governments Do To Avoid Their Country Becoming a Nursing Home? ChapterSeven: Bioscience's Disruptive InfluencesInsurance and Healthcare; Real Estate; Politics; Geopolitics; Retail Goods and Services; The Food Industry; The Investment Industry; The Law; Shortage of Young People in Developed Nations; ChapterEight: Robotics and Nanotechnology; Robotics; Surgical Procedures/Surgical Assistance; Medical Monitor/Nurse; Housemaid/Domestic Assistance; Companion/Pet; Nanotechnology; ChapterNine: Lifestyle Maintenance; It's a Fact: Obesity Shortens your Life; Extending Life Expectancy; Common Traits of People who Live the Longest; A "Cure" to Ageing Telomeres - Our Biological ClockChapterTen: Investment in Biopharma - Chasing Those Money Fountains; Conservative Portfolio; Balanced Portfolio; Speculative Portfolio; Company Overviews; Summary; Glossary; Appendix - Key Financial Charts of Big Pharma; References; Bibliography; Index |
Record Nr. | UNINA-9910461624903321 |
Mellon Jim | ||
Chichester, West Sussex, U.K., : Wiley, 2012 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Cracking the code [[electronic resource] ] : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi |
Autore | Mellon Jim |
Pubbl/distr/stampa | Chichester, West Sussex, U.K., : Wiley, 2012 |
Descrizione fisica | 1 online resource (362 p.) |
Disciplina | 338.4/76151 |
Altri autori (Persone) | ChalabiAl |
Soggetto topico |
Biotechnology industries - Finance
Pharmaceutical industry - Finance Biotechnology industries Pharmaceutical industry Investments |
ISBN |
1-119-96937-9
1-280-67915-8 9786613656087 1-119-96936-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cracking the Code; Contents; Acknowledgements; Introduction; ChapterOne: Transformational Technologies; Futurists and Scientists Look into the Future; The Convergence of Technology and Biology; ChapterTwo: The Evolution of Medicine and the Emergence of Biopharma; From Atoms to Cells to Living Organisms; The History of the Pharmaceutical Industry; ChapterThree: The Drug Industry - Reinventing the Model; Big Pharma, Biopharma; Drug Patents; The Path to Riches: FDA Approval; In Summary; ChapterFour: Curing Disease - Promising Prospects in the Main Therapeutic Areas
Cancer - Step by Step, Being BeatenInfectious Diseases: New Antibiotics, Hepatitis and HIV Drugs Make for a Fast-growing Sector; Obesity and its Evil Sisters: Type 2 Diabetes and Kidney Disease; The Heart of the Matter - Biggest Killer on the Prowl; Fading into the Night - Neurodegeneration, Rheumatology and Multiple Sclerosis; Respiratory Disease - New Drugs: A Breath of Fresh Air; Rare Diseases and Rare Profits; Drugs for Pain and for the Central Nervous System; The Best of the Rest - Ophthalmology, Dermatology, Gastrointestinal and Bone Disease ChapterFive: Turning Back the Clock - Stem Cells, Genomics, Gene Therapy and RegenerationStem Cells; Gene Therapy and Nano Medicine; Organ Growth in and out of the Body; ChapterSix: Demographic Changes; The Working Age Labour Pool in the World is Shrinking; Can Immigration Solve the Labour Shortage in the Developed World?; The Social Impact of an Ageing Population; The United States is the Best Positioned Developed Country; Support Ratios Have Been Plummeting; China's Grey Future; What Can Governments Do To Avoid Their Country Becoming a Nursing Home? ChapterSeven: Bioscience's Disruptive InfluencesInsurance and Healthcare; Real Estate; Politics; Geopolitics; Retail Goods and Services; The Food Industry; The Investment Industry; The Law; Shortage of Young People in Developed Nations; ChapterEight: Robotics and Nanotechnology; Robotics; Surgical Procedures/Surgical Assistance; Medical Monitor/Nurse; Housemaid/Domestic Assistance; Companion/Pet; Nanotechnology; ChapterNine: Lifestyle Maintenance; It's a Fact: Obesity Shortens your Life; Extending Life Expectancy; Common Traits of People who Live the Longest; A "Cure" to Ageing Telomeres - Our Biological ClockChapterTen: Investment in Biopharma - Chasing Those Money Fountains; Conservative Portfolio; Balanced Portfolio; Speculative Portfolio; Company Overviews; Summary; Glossary; Appendix - Key Financial Charts of Big Pharma; References; Bibliography; Index |
Record Nr. | UNINA-9910790277003321 |
Mellon Jim | ||
Chichester, West Sussex, U.K., : Wiley, 2012 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Cracking the code : understand and profit from the biostech revolution that will transform our lives and generate fortunes / / Jim Mellon & Al Chalabi |
Autore | Mellon Jim |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Chichester, West Sussex, U.K., : Wiley, 2012 |
Descrizione fisica | 1 online resource (362 p.) |
Disciplina | 338.4/76151 |
Altri autori (Persone) | ChalabiAl |
Soggetto topico |
Biotechnology industries - Finance
Pharmaceutical industry - Finance Biotechnology industries Pharmaceutical industry Investments |
ISBN |
1-119-96937-9
1-280-67915-8 9786613656087 1-119-96936-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cracking the Code; Contents; Acknowledgements; Introduction; ChapterOne: Transformational Technologies; Futurists and Scientists Look into the Future; The Convergence of Technology and Biology; ChapterTwo: The Evolution of Medicine and the Emergence of Biopharma; From Atoms to Cells to Living Organisms; The History of the Pharmaceutical Industry; ChapterThree: The Drug Industry - Reinventing the Model; Big Pharma, Biopharma; Drug Patents; The Path to Riches: FDA Approval; In Summary; ChapterFour: Curing Disease - Promising Prospects in the Main Therapeutic Areas
Cancer - Step by Step, Being BeatenInfectious Diseases: New Antibiotics, Hepatitis and HIV Drugs Make for a Fast-growing Sector; Obesity and its Evil Sisters: Type 2 Diabetes and Kidney Disease; The Heart of the Matter - Biggest Killer on the Prowl; Fading into the Night - Neurodegeneration, Rheumatology and Multiple Sclerosis; Respiratory Disease - New Drugs: A Breath of Fresh Air; Rare Diseases and Rare Profits; Drugs for Pain and for the Central Nervous System; The Best of the Rest - Ophthalmology, Dermatology, Gastrointestinal and Bone Disease ChapterFive: Turning Back the Clock - Stem Cells, Genomics, Gene Therapy and RegenerationStem Cells; Gene Therapy and Nano Medicine; Organ Growth in and out of the Body; ChapterSix: Demographic Changes; The Working Age Labour Pool in the World is Shrinking; Can Immigration Solve the Labour Shortage in the Developed World?; The Social Impact of an Ageing Population; The United States is the Best Positioned Developed Country; Support Ratios Have Been Plummeting; China's Grey Future; What Can Governments Do To Avoid Their Country Becoming a Nursing Home? ChapterSeven: Bioscience's Disruptive InfluencesInsurance and Healthcare; Real Estate; Politics; Geopolitics; Retail Goods and Services; The Food Industry; The Investment Industry; The Law; Shortage of Young People in Developed Nations; ChapterEight: Robotics and Nanotechnology; Robotics; Surgical Procedures/Surgical Assistance; Medical Monitor/Nurse; Housemaid/Domestic Assistance; Companion/Pet; Nanotechnology; ChapterNine: Lifestyle Maintenance; It's a Fact: Obesity Shortens your Life; Extending Life Expectancy; Common Traits of People who Live the Longest; A "Cure" to Ageing Telomeres - Our Biological ClockChapterTen: Investment in Biopharma - Chasing Those Money Fountains; Conservative Portfolio; Balanced Portfolio; Speculative Portfolio; Company Overviews; Summary; Glossary; Appendix - Key Financial Charts of Big Pharma; References; Bibliography; Index |
Record Nr. | UNINA-9910825483003321 |
Mellon Jim | ||
Chichester, West Sussex, U.K., : Wiley, 2012 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Devalued and distrusted [[electronic resource] ] : can the pharmaceutical industry restore its broken image? / / John L. LaMattina |
Autore | LaMattina John L |
Pubbl/distr/stampa | Hoboken, N.J., : Wiley, 2013 |
Descrizione fisica | 1 online resource (137 p.) |
Disciplina | 338.4/76151 |
Soggetto topico | Pharmaceutical industry - Corrupt practices |
ISBN |
1-118-51132-8
1-283-91742-4 1-118-51129-8 |
Classificazione | MED071000 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Machine generated contents note: Introduction Part 1. "The 4 Secrets That Drug Companies Don't Want You to Know" Part 2. What Has Happened to R&D Productivity? a. Impact of Mergers b. Impact of FDA c. Impact of Payers Part 3. Challenges in Key Therapeutic Areas for Improving Health a. Cancer b. Diseases of the Brain c. Cardiovascular Disease d. Diabetes e. Bacterial Infections Part 4. Improving R&D Output a. View of Others b. Personal Vision Part 5. Restoring the Pharma Image Part 6. Final Thoughts. |
Record Nr. | UNINA-9910141533103321 |
LaMattina John L | ||
Hoboken, N.J., : Wiley, 2013 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Devalued and distrusted : can the pharmaceutical industry restore its broken image? / / John L. LaMattina |
Autore | LaMattina John L |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Hoboken, N.J., : Wiley, 2013 |
Descrizione fisica | 1 online resource (137 p.) |
Disciplina | 338.4/76151 |
Soggetto topico | Pharmaceutical industry - Corrupt practices |
ISBN |
1-118-51132-8
1-283-91742-4 1-118-51129-8 |
Classificazione | MED071000 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Machine generated contents note: Introduction Part 1. "The 4 Secrets That Drug Companies Don't Want You to Know" Part 2. What Has Happened to R&D Productivity? a. Impact of Mergers b. Impact of FDA c. Impact of Payers Part 3. Challenges in Key Therapeutic Areas for Improving Health a. Cancer b. Diseases of the Brain c. Cardiovascular Disease d. Diabetes e. Bacterial Infections Part 4. Improving R&D Output a. View of Others b. Personal Vision Part 5. Restoring the Pharma Image Part 6. Final Thoughts. |
Record Nr. | UNINA-9910824681403321 |
LaMattina John L | ||
Hoboken, N.J., : Wiley, 2013 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Drug compounding pharmacies : risk and oversight issues / / Seth Sharpe, editor |
Pubbl/distr/stampa | [Hauppauge] New York : , : Nova Publishers, , [2013] |
Descrizione fisica | 1 online resource (184 pages) |
Disciplina | 338.4/76151 |
Collana |
Pharmacology, research, safety testing and regulation
Public health in the 21st century |
Soggetto topico |
Pharmaceutical technology - Standards
Pharmaceutical industry - United States - Quality control Products liability - Drugs - United States |
ISBN | 1-62808-177-5 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910151722103321 |
[Hauppauge] New York : , : Nova Publishers, , [2013] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Drug discovery today Therapeutic strategies |
Pubbl/distr/stampa | [Amsterdam] ; ; [New York, NY], : Elsevier, ©2004-[2013] |
Descrizione fisica | 1 online resource |
Disciplina | 338.4/76151 |
Soggetto topico |
Pharmaceutical industry
Drug development Drugs - Design Biopharmaceutics Clinical pharmacology Drug Therapy Drug Design |
Soggetto genere / forma | Periodicals. |
Soggetto non controllato | Industries |
ISSN | 1740-6773 |
Formato | Materiale a stampa |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Altri titoli varianti | Therapeutic strategies |
Record Nr. | UNISA-996216406303316 |
[Amsterdam] ; ; [New York, NY], : Elsevier, ©2004-[2013] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. di Salerno | ||
|